Skip to main content

Animations

MJFF Publications

3191 - 3200 of 9036 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2023
  • 2023
  • 2024
  • 2024
  • 2023
  • 2024
  • 2023
  • 2024
  • Summary Details
    OPEN
    Title: Radiomic tractometry reveals tract-specific imaging biomarkers in white matter
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-44591-3
    Citation Count: 18
  • Summary Details
    OPEN
    Title: A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00624-8
    Citation Count: 25
  • Summary Details
    OPEN
    Title: PyRates—A code-generation tool for modeling dynamical systems in biology and beyond
    Journal Name: PLOS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1011761
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Prevalence and impact of neuropsychiatric symptoms in normal aging and neurodegenerative syndromes: A population‐based study from Latin America
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.13384
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Targeted micro-fiber arrays for measuring and manipulating localized multi-scale neural dynamics over large, deep brain volumes during behavior
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuron.2023.12.011
    Citation Count: 22
  • Summary Details
    OPEN
    Title: SRF transcriptionally regulates the oligodendrocyte cytoskeleton during CNS myelination
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2307250121
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE‐PD Open‐Label Extension Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29685
    Citation Count: 8
  • Summary Details
    OPEN
    Title: α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-024-00401-4
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Genetic Testing in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29500
    Citation Count: 30
  • Summary Details
    OPEN
    Title: AccessPD as a next generation registry to accelerate Parkinson’s disease research
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00651-z
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.